Jan Zijlstra
Jan Zijlstra
Unknown affiliation
Verified email at planet.nl
Title
Cited by
Cited by
Year
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
D Annane, V Sébille, C Charpentier, PE Bollaert, B François, JM Korach, ...
Jama 288 (7), 862-871, 2002
37492002
A randomized trial of glutamine and antioxidants in critically ill patients
D Heyland, J Muscedere, PE Wischmeyer, D Cook, G Jones, M Albert, ...
New England Journal of Medicine 368 (16), 1489-1497, 2013
907*2013
Decontamination of the digestive tract and oropharynx in ICU patients
A De Smet, J Kluytmans, BS Cooper, EM Mascini, RFJ Benus, ...
New England Journal of Medicine 360 (1), 20-31, 2009
8332009
Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line
JG Zijlstra, EGE de Vries, NH Mulder
Cancer Research 47 (7), 1780-1784, 1987
3201987
Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials
JL Vincent, RJ Navickis, MM Wilkes
Critical care medicine 32 (10), 2029-2038, 2004
2522004
Leukocyte activation in sepsis; correlations with disease state and mortality
ACM Kobold, JE Tulleken, JG Zijlstra, W Sluiter, J Hermans, ...
Intensive care medicine 26 (7), 883-892, 2000
2382000
Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature
S Meijering, AM Corstjens, JE Tulleken, JHJM Meertens, JG Zijlstra, ...
Critical Care 10 (1), 1-7, 2006
2232006
Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients
AM Corstjens, JJM Ligtenberg, ICC van der Horst, R Spanjersberg, ...
Critical Care 10 (5), 1-7, 2006
1932006
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line
S de Jong, JG Zijlstra, EGE de Vries, NH Mulder
Cancer research 50 (2), 304-309, 1990
1861990
Quality of interhospital transport of critically ill patients: a prospective audit
JJM Ligtenberg, LG Arnold, Y Stienstra, TS van der Werf, JHJM Meertens, ...
Critical Care 9 (4), 1-6, 2005
1802005
Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD
ML Duiverman, JB Wempe, G Bladder, DF Jansen, HAM Kerstjens, ...
Thorax 63 (12), 1052-1057, 2008
1742008
Increased circulating endothelial progenitor cells in septic patients: correlation with survival
N Rafat, C Hanusch, PT Brinkkoetter, J Schulte, J Brade, JG Zijlstra, ...
Critical care medicine 35 (7), 1677-1684, 2007
1592007
Blunted rise in platelet count in critically ill patients is associated with worse outcome
MWN Nijsten, HJ ten Duis, JG Zijlstra, RJ Porte, JH Zwaveling, JC Paling
Critical care medicine 28 (12), 3843-3846, 2000
1582000
Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial
ML Duiverman, JB Wempe, G Bladder, JM Vonk, JG Zijlstra, ...
Respiratory research 12 (1), 1-10, 2011
1472011
Quality of interhospital transport of the critically ill: impact of a Mobile Intensive Care Unit with a specialized retrieval team
JS Wiegersma, JM Droogh, JG Zijlstra, J Fokkema, JJM Ligtenberg
Critical care 15 (1), 1-8, 2011
1452011
Bench-to-bedside review: Angiopoietin signalling in critical illness–a future target?
M van Meurs, P Kümpers, JJM Ligtenberg, JHJM Meertens, G Molema, ...
Critical care 13 (2), 1-13, 2009
1442009
Organophosphorus pesticide poisoning: cases and developments
H Aardema, JH Meertens, JJ Ligtenberg, OM Peters-Polman, JE Tulleken, ...
Neth J Med 66 (4), 149-53, 2008
1442008
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide …
AGJ van der Zee, H Hollema, S de Jong, H Boonstra, A Gouw, ...
Cancer research 51 (21), 5915-5920, 1991
1421991
Transferring the critically ill patient: are we there yet?
JM Droogh, M Smit, AR Absalom, JJM Ligtenberg, JG Zijlstra
Critical Care 19 (1), 1-7, 2015
1382015
Suppression of the clinical and cytokine response to endotoxin by RWJ‐67657, a p38 mitogen‐activated protein‐kinase inhibitor, in healthy human volunteers
JW Fijen, JG Zijlstra, P De Boer, R Spanjersberg, JW Cohen Tervaert, ...
Clinical & Experimental Immunology 124 (1), 16-20, 2001
1322001
The system can't perform the operation now. Try again later.
Articles 1–20